Pharmaceutical giant Pfizer has recalled three varieties of blood pressure medication, citing cancer risks for patients. What do you need to know about this sweeping new recall action? Read on for more details regarding which medications are affected and what you need to do if you’ve been prescribed any of these recalled drugs.
The American pharmaceutical company announced the drug recall earlier this week. According to Pfizer, the prescription blood pressure medicine Accuretic and its two generic offshoots contain unsafe levels of nitrosamine. The recall notice points out that the medications contain nitrosamine levels far exceeding the FDA’s Acceptable Daily Intake, which could pose a risk to patients.
Nitrosamine is a possible carcinogenic substance. Some studies suggest that prolonged exposure to nitrosamine above ADI levels could increase patients’ risk of developing certain cancers. Officials note that people contact nitrosamine in some foods, tap water, and some dairy products. However, the FDA regulates how much nitrosamine appears in these sources, given the chemical’s possible carcinogenic properties.
The affected drugs were produced between November 2019 and March 2022. If you’ve purchased any of these medications, Pfizer encourages you to discard them.
Accuretic is a blood pressure drug prescribed to treat high blood pressure and hypertension to reduce the risk of heart attacks and strokes. Patients might also purchase the generic medication quinapril and hydrochlorothiazide, or quinapril HCI/hydrochlorothiazide. These medications are also subject to recall due to their unacceptable nitrosamine levels.
Pfizer recommends patients who take these medications talk to their doctors about alternative treatment options. Pfizer encourages patients to discontinue the use of Accuretic and generic counterparts to reduce their exposure to carcinogens.
The manufacturer is pulling six lots of Accuretic tablets and five lots of generic medications to prevent them from reaching pharmacies. Patients waiting for refills on these drugs need to speak to their doctors for alternative treatment options.
Pfizer has instructed wholesalers and distributors to cease the sale of Accuretic and its generic counterparts immediately and to quarantine the products. Patients with questions should direct them to their doctors, who can recommend both short- and long-term alternatives to Accuretic to avoid patient exposure to nitrosamine.
Pfizer has posted a complete notice regarding the recall on its official website. Customers can contact Pfizer at 1-800-879-3477 between 9:00 AM and 7:00 PM, Eastern Time, on Mondays through Fridays.